The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUMB. M. Feldman, V. Blanchette, Paul Giangrande et al.|Haemophilia|2007Cited by 22
Are randomized clinical trials the only truth? Not alwaysLouis M. Aledort, V. Blanchette, Rolf Ljung|Journal of Thrombosis and Haemostasis|2006Cited by 15
Unresolved issues in prophylaxisSimon Brown, W. Schramm, Nick Poulios et al.|Haemophilia|2002Cited by 11